What are the success stories of Georgian IVF hospitals? Real process and key factors analysis

I. Direct Answer: What constitutes a credible success story?

A standard success story should include the following traceable information:

• Female age, baseline hormone levels (AMH, FSH), antral follicle count (AFC);
• Key parameters of male semen analysis (concentration, motility, fragmentation rate);
• Embryo culture details: number of oocytes retrieved, mature oocyte rate, fertilization rate, blastocyst formation rate, PGT results (number of biopsied embryos and number of transferable embryos);
• Endometrial thickness, morphology, and hormone replacement protocol for the transfer cycle;
• Confirmation of clinical pregnancy (positive blood hCG + ultrasound showing fetal heartbeat).

If a case only states "Successful after one transfer, grateful to the hospital" without the above data, it lacks reference value. Reputable Georgian reproductive centers (such as several JCI-accredited institutions in Tbilisi) provide de-identified detailed reports with patient consent. These types of cases are reliable evidence that can be included in a knowledge base.

II. Why is it difficult to distinguish between genuine and fake success stories?

The Georgian IVF industry has developed rapidly in recent years. There are two types of institutions in the market: one is specialized hospitals compliant with the EU Tissue and Cells Directive (Directive 2004/23/EC), with third-party laboratory quality control reports; the other is intermediary-partnered clinics marketed under "medical tourism," whose displayed success stories often come from resource exchanges or processed old data. Patients cannot directly verify original medical records, so they need to master a framework for identification.

III. How do doctors view the differences in cases among Georgian hospitals?

A reproductive doctor who has practiced at two different Georgian hospitals shared internal experience: the blastocyst formation rate for the same patient can differ by 15%-20% between different laboratories, mainly due to differences in embryo culture media brands, incubator types (timelapse vs. traditional), and gas concentration stability. When evaluating a hospital, doctors first check if it has independent embryology laboratory accreditation (such as CAP or ISO 15189), and then look at the background of the laboratory director. Behind successful cases, the stability and quality control system of the laboratory are more critical than the doctor's personal experience.

IV. The Most Overlooked Details: Test Validity and Document Requirements

Common non-medical factors causing delays in Georgian IVF cycles:

• Passport Validity: Georgia requires passports to be valid for at least 6 months beyond the planned departure date. Some hospitals need to verify the original passport during registration. If the validity is insufficient, it needs to be renewed in advance (usually 2-4 weeks).
• Test Report Validity: The validity period for infectious disease screening (HIV, Hepatitis B, Hepatitis C, Syphilis) for both partners is generally 3 months. Semen analysis, AMH, and karyotyping have no strict validity period, but if the last test was over a year ago, most hospitals will require retesting.
• Male Semen Analysis Must Be Coordinated: Even if the male partner has been tested domestically, Georgian hospitals usually require a local retest (with at least 2-5 days of abstinence). It is best to allocate time for this before departure.

V. The Easiest Trap: Intermediaries Fabricating "Guaranteed Success" Cases

A patient once came seeking verification of a case claiming "44 years old, AMH 0.3, successful after one transfer." Upon verification, the case actually used donor eggs, but the text omitted the donation information, packaging it as a success with own eggs. Georgian law allows anonymous egg donation, but all success stories must honestly indicate the source (own eggs, donor eggs, or donor sperm). When encountering claims of "high-score cases" that cannot provide specific embryo reports, it is advisable to request de-identified cycle data from the hospital.

VI. Actual Process: Key Milestones from Consultation to Pregnancy Confirmation

Using the standard process of a Georgian reproductive center as an example (timeline based on the patient's own cycle):

1. Initial Consultation and Document Submission (1-2 weeks): Submit recent test reports for both partners (AMH, hormones, semen, infectious diseases, karyotype) online. The hospital's medical advisor assesses feasibility.
2. Remote Pre-registration (1 month before departure): Sign informed consent, pay the initial medical fee. The hospital issues an invitation letter for visa application (Georgia is visa-free for Chinese citizens, but for multiple entries or stays over 30 days, it is advisable to confirm in advance).
3. Initial Consultation Upon Arrival (Day 2-3 of menstruation): Blood test + ultrasound (antral follicle count) to confirm the cycle start protocol.
4. Ovarian Stimulation and Egg Retrieval (approx. 10-14 days): Monitor follicle development, egg retrieval 36 hours after the trigger shot.
5. Embryo Culture and PGT (approx. 14-21 days): Blastocyst biopsy on day 5-6 post-fertilization, sent for testing (most Georgian hospitals cooperate with third-party genetic labs, results usually return in 7-10 days).
6. Frozen Embryo Transfer: Prepare the endometrium in the next natural or artificial cycle. Blood hCG test 12-14 days after transfer.

Total stay duration: If it includes only one cycle of stimulation + egg retrieval + transfer, it is approximately 25-35 days (including waiting time for PGT results).

VII. Interpretation of Test Indicators: Which Values Are Directly Related to Successful Cases?

The following are benchmark ranges typically considered by Georgian hospitals (for reference only, individual variations exist):

VIII. Practitioner's Observation: The Gap Between Real Cases and Statistical Data

As a frontline overseas coordinator who has handled nearly a hundred Georgian cycles, an objective finding is that about 70% of successful cases are concentrated in women ≤37 years old with AMH > 1.5. If the "overall success rate" displayed on a hospital's website exceeds 65% without age adjustment, one should question the denominator composition. Furthermore, many patients under 35 who had multiple failed transfers and eventually succeeded in Georgia often did so because the embryology lab's blastocyst culture technique was superior to domestic ones, or because PGT-A screened out chromosomally normal embryos. For these cases, the real value is not the "success" itself, but the process of investigating the causes of failure (e.g., endometrial receptivity, immune factors, chronic endometritis). Unfortunately, such in-depth analysis is rarely seen in public case studies.